Northwestern Mutual Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $243K | Sell |
1,072
-21
| -2% | -$3.74K | ﹤0.01% | 1920 |
|
|
2026
Q1 | $189K | Sell |
1,093
-9
| -0.8% | -$1.67K | ﹤0.01% | 1930 |
|
|
2025
Q4 | $220K | Buy |
1,102
+6
| +0.5% | +$1.09K | ﹤0.01% | 1828 |
|
|
2025
Q3 | $172K | Sell |
1,096
-34
| -3% | -$5.4K | ﹤0.01% | 1861 |
|
|
2025
Q2 | $172K | Sell |
1,130
-23,716
| -95% | -$3.16M | ﹤0.01% | 1801 |
|
|
2025
Q1 | $3.74M | Buy |
24,846
+23,152
| +1,367% | +$3.88M | ﹤0.01% | 738 |
|
|
2024
Q4 | $313K | Buy |
1,694
+258
| +18% | +$49.7K | ﹤0.01% | 1482 |
|
|
2024
Q3 | $283K | Sell |
1,436
-49,015
| -97% | -$10.2M | ﹤0.01% | 1511 |
|
|
2024
Q2 | $10.4M | Buy |
50,451
+6,011
| +14% | +$1.36M | 0.01% | 410 |
|
|
2024
Q1 | $12M | Buy |
44,440
+2,347
| +6% | +$560K | 0.01% | 381 |
|
|
2023
Q4 | $9.95M | Buy |
42,093
+2,821
| +7% | +$555K | 0.01% | 404 |
|
|
2023
Q3 | $7.7M | Buy |
39,272
+38,234
| +3,683% | +$7.85M | 0.01% | 408 |
|
|
2023
Q2 | $218K | Buy |
1,038
+15
| +1% | +$2.98K | ﹤0.01% | 1426 |
|
|
2023
Q1 | $207K | Buy |
1,023
+38
| +4% | +$8.61K | ﹤0.01% | 1426 |
|
|
2022
Q4 | $215K | Sell |
985
-184
| -16% | -$40.2K | ﹤0.01% | 1397 |
|
|
2022
Q3 | $231K | Sell |
1,169
-19
| -2% | -$4.1K | ﹤0.01% | 1347 |
|
|
2022
Q2 | $253K | Buy |
1,188
+188
| +19% | +$45.9K | ﹤0.01% | 1314 |
|
|
2022
Q1 | $285K | Buy |
1,000
+297
| +42% | +$91.6K | ﹤0.01% | 1303 |
|
|
2021
Q4 | $265K | Buy |
703
+96
| +16% | +$37.3K | ﹤0.01% | 1314 |
|
|
2021
Q3 | $250K | Buy |
607
+54
| +10% | +$22.4K | ﹤0.01% | 1269 |
|
|
2021
Q2 | $205K | Sell |
553
-968
| -64% | -$323K | ﹤0.01% | 1307 |
|
|
2021
Q1 | $441K | Sell |
1,521
-2,000
| -57% | -$556K | ﹤0.01% | 963 |
|
|
2020
Q4 | $880K | Buy |
3,521
+879
| +33% | +$209K | ﹤0.01% | 676 |
|
|
2020
Q3 | $598K | Buy |
2,642
+2,517
| +2,014% | +$522K | ﹤0.01% | 713 |
|
|
2020
Q2 | $22K | Sell |
125
-41
| -25% | -$6.54K | ﹤0.01% | 1681 |
|
|
2020
Q1 | $21K | Sell |
166
-4,062
| -96% | -$609K | ﹤0.01% | 1680 |
|
|
2019
Q4 | $646K | Buy |
4,228
+68
| +2% | +$9.41K | ﹤0.01% | 626 |
|
|
2019
Q3 | $551K | Buy |
4,160
+111
| +3% | +$14.9K | ﹤0.01% | 622 |
|
|
2019
Q2 | $575K | Buy |
4,049
+101
| +3% | +$13.7K | ﹤0.01% | 595 |
|
|
2019
Q1 | $573K | Buy |
3,948
+3,850
| +3,929% | +$506K | ﹤0.01% | 591 |
|
|
2018
Q4 | $11K | Sell |
98
-98
| -50% | -$12.3K | ﹤0.01% | 1788 |
|
|
2018
Q3 | $26K | Hold |
196
| – | – | ﹤0.01% | 1553 |
|
|
2018
Q2 | $22K | Hold |
196
| – | – | ﹤0.01% | 1557 |
|
|
2018
Q1 | $21K | Sell |
196
-39
| -17% | -$4.2K | ﹤0.01% | 1509 |
|
|
2017
Q4 | $26K | Buy |
235
+15
| +7% | +$1.63K | ﹤0.01% | 1413 |
|
|
2017
Q3 | $24K | Buy |
220
+24
| +12% | +$2.47K | ﹤0.01% | 1404 |
|
|
2017
Q2 | $20K | Buy |
196
+68
| +53% | +$6.26K | ﹤0.01% | 1388 |
|
|
2017
Q1 | $12K | Buy |
128
+46
| +56% | +$3.91K | ﹤0.01% | 1477 |
|
|
2016
Q4 | $6K | Buy |
82
+25
| +44% | +$1.9K | ﹤0.01% | 1771 |
|
|
2016
Q3 | $5K | Hold |
57
| – | – | ﹤0.01% | 1733 |
|
|
2016
Q2 | $4K | Buy |
57
+30
| +111% | +$2.47K | ﹤0.01% | 1639 |
|
|
2016
Q1 | $2K | Buy |
+27
| New | +$2K | ﹤0.01% | 1873 |
|
|
2015
Q1 | – | Sell |
-200
| Closed | -$13K | – | 1587 |
|
|
2014
Q4 | $13K | Hold |
200
| – | – | ﹤0.01% | 991 |
|
|
2014
Q3 | $12K | Hold |
200
| – | – | ﹤0.01% | 895 |
|
|
2014
Q2 | $11K | Hold |
200
| – | – | ﹤0.01% | 880 |
|
|
2014
Q1 | $12K | Hold |
200
| – | – | ﹤0.01% | 838 |
|
|
2013
Q4 | $11K | Hold |
200
| – | – | ﹤0.01% | 902 |
|
|
2013
Q3 | $9K | Hold |
200
| – | – | ﹤0.01% | 894 |
|
|
2013
Q2 | $8K | Buy |
+200
| New | +$8.57K | ﹤0.01% | 884 |
|
Other funds holding CRL
AI
Northwestern Mutual Wealth Management's CRL Position: Q2 2026 in Review
Northwestern Mutual Wealth Management reduced its Charles River Laboratories (CRL) stake by 1.9% in Q2 2026, selling an estimated $3.74K and leaving 1,072 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1920.
Northwestern Mutual Wealth Management first reported a position in CRL in Q2 2013 and has held it in 49 quarters since. The position peaked at $12M in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Northwestern Mutual Wealth Management held 1,072 shares of Charles River Laboratories worth $243K as of Q2 2026.
- Northwestern Mutual Wealth Management sold 21 Charles River Laboratories shares in Q2 2026, an estimated $3.74K.
- Charles River Laboratories made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1920 holding.
- Northwestern Mutual Wealth Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 49 quarters since.
- Northwestern Mutual Wealth Management's Charles River Laboratories position peaked at $12M in Q1 2024.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.